XML 34 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Stock-Based Compensation Expense by Award Type

The Company’s stock-based compensation expense by award type was as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Stock options

 

$

6,965

 

 

$

4,309

 

 

$

19,261

 

 

$

11,248

 

Restricted stock units

 

 

69

 

 

 

69

 

 

 

206

 

 

 

206

 

Employee stock purchase plan

 

 

128

 

 

 

105

 

 

 

512

 

 

 

301

 

 

 

$

7,162

 

 

$

4,483

 

 

$

19,979

 

 

$

11,755

 

Stock-Based Compensation Expense

The Company has recorded aggregate stock-based compensation expense in the consolidated statements of operations and comprehensive income (loss) as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Research and development

 

$

3,657

 

 

$

1,940

 

 

$

9,530

 

 

$

5,364

 

General and administrative

 

 

3,505

 

 

 

2,543

 

 

 

10,449

 

 

 

6,391

 

 

 

$

7,162

 

 

$

4,483

 

 

$

19,979

 

 

$

11,755

 

Summary of Unvested RSUs Activity Under 2015 Plan

The following table summarizes restricted stock unit activity under the 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested balance at December 31, 2018

 

 

40

 

 

$

20.90

 

Granted

 

 

 

 

$

 

Vested

 

 

 

 

$

 

Forfeited

 

 

 

 

$

 

Unvested balance at September 30, 2019

 

 

40

 

 

$

20.90

 

2014 and 2015 Equity Incentive Plan [Member]  
Summary of Stock Option Activity

The following table summarizes stock option activity under the 2014 Plan and 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

average

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Life

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

(Years)

 

 

Value (a)

 

Outstanding at December 31, 2018

 

 

4,855

 

 

$

19.31

 

 

 

7.6

 

 

$

118,185

 

Granted

 

 

1,596

 

 

$

47.82

 

 

 

 

 

 

 

 

 

Exercised

 

 

(684

)

 

$

8.07

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(237

)

 

$

33.74

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2019

 

 

5,530

 

 

$

28.31

 

 

 

7.7

 

 

$

69,769

 

Exercisable at September 30, 2019

 

 

2,827

 

 

$

15.48

 

 

 

6.6

 

 

$

60,340

 

Vested and expected to vest at September 30, 2019

 

 

5,530

 

 

$

28.31

 

 

 

7.7

 

 

$

69,769

 

 

(a)

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that were in the money at the dates reported.